[Effectiveness of a combined live mumps-measles vaccine]. 1987

S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva

The reactogenic and areactogenic properties of a live combined mumps-measles vaccine (MMV) prepared in primary cultures of Japanese quail embryo cells from attenuated strains of mumps (L-3) and measles (L-16) viruses were under study. The observations involved 648 infants varying in ages from 1 to 3 years, seronegative to measles and mumps viruses, without the history of the disease and vaccinations against these infections or contraindications to vaccinations. The infants were vaccinated with 5 batches of MMV with different portions of the mumps and measles components. The vaccinees and controls (placebo injections) were observed for 30 days postvaccination. The live MMV was shown to be a safe, well tolerated preparation with low reactogenicity and a high antigenic activity.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D009108 Mumps Vaccine Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine. Inactivated Mumps Vaccine,Inactivated Mumps Virus Vaccine,Live Attenuated Mumps Vaccine,Live Attenuated Mumps Virus Vaccine,Mumps Vaccine, Inactivated,Mumps Vaccine, Live Attenuated,Mumps Virus Vaccine, Inactivated,Mumps Virus Vaccine, Live Attenuated,Vaccine, Inactivated Mumps,Vaccine, Mumps
D009109 Mumps virus The type species of RUBULAVIRUS that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection. Epidemic Parotitis Virus,Myxovirus parotitidis,Epidemic Parotitis Viruses,Mumps viruses
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
July 1973, Archives of disease in childhood,
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
May 1971, American journal of diseases of children (1960),
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
May 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
May 1975, Monatsschrift fur Kinderheilkunde,
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
January 1970, Bulletin of the World Health Organization,
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
June 1973, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
January 1985, Trudy Instituta imeni Pastera,
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
May 1972, American journal of diseases of children (1960),
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
March 1969, JAMA,
S S Unanov, and Iu N Korzh, and V M Dorofeev, and N V Iuminova, and L A Myshliaeva
January 1986, Developments in biological standardization,
Copied contents to your clipboard!